About
Small Molecules for Cancer
Areas of Focus
Categories
Small Molecule PharmaceuticalNorth & South Carolina
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
3
As Collaborator
3
Total Enrollment
429
By Phase
NA: 5PHASE4: 1
By Status
COMPLETED: 5RECRUITING: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT07126717Lead Sponsor
Acute Effects of Zynamite® S in Cognitive Function and Mood
NACompleted
88 participants
Started: May 12, 2025 · Completed: Jun 9, 2025
NCT06317805Collaborator
Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients
PHASE4Recruiting
110 participants
Started: Dec 6, 2023 · Completed: Jun 30, 2027
NCT06463145Lead Sponsor
Study of the Anxiolytic Effects of Aframomum Seed Extract in Elderly People
NACompleted
37 participants
Started: Mar 1, 2023 · Completed: May 20, 2023
NCT05580146Collaborator
Acute Dose-ranging Effects of Mango Leaf Extract (Zynamite® 15%) on Cognitive Function and Cerebral Blood Flow
NACompleted
62 participants
Started: May 17, 2021 · Completed: Apr 14, 2022
NCT04299217Collaborator
Acute Effects of Mango Leaf Extract (Zynamite®) on Cognitive Function, Mood and Stress
NACompleted
75 participants
Started: Nov 4, 2019 · Completed: Mar 17, 2020
Locations (1)
Headquarters
Cary, NC, United States
Map
Loading map...